Search - tctmd.com

Displaying 1 - 20 of 198

Sort: Relevancy | Date

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

Presentation TCT 2016

TCT 519: Correlation Between Invasive CFR AND Echocardiographic Parameters in Severe Aortic Stenosis

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

TCT 518: The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI.

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

Presentation TCT 2016

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis.

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

The Case for Sutureless/ Rapid Deployment Valves

Presenter: Michael A. Borger, Vinod H. Thourani

November 01, 2016

Presentation TCT 2016

The Case for TAVR

Presenter: Michael A. Borger, Vinod H. Thourani, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Gregg W. Stone, Philippe Pibarot, Susheel K. Kodali

November 01, 2016

Presentation TCT 2016

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic and Mitral Stenosis

Presenter: Jean-Claude Laborde, Thomas Walther, Ulrich Schafer

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Ori Ben-Yehuda

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Advertisement

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

TCT 519: Correlation Between Invasive CFR AND Echocardiographic Parameters in Severe Aortic Stenosis

TCT 518: The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis

TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI.

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis.

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

The Case for Sutureless/ Rapid Deployment Valves

The Case for TAVR

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic and Mitral Stenosis

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content